19-11060071-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001387283.1(SMARCA4):c.4891C>T(p.Leu1631Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1631I) has been classified as Uncertain significance.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4891C>T | p.Leu1631Phe | missense_variant | Exon 35 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.4795C>T | p.Leu1599Phe | missense_variant | Exon 34 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.4801C>T | p.Leu1601Phe | missense_variant | Exon 34 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.4705C>T | p.Leu1569Phe | missense_variant | Exon 34 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.4705C>T | p.Leu1569Phe | missense_variant | Exon 33 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.4705C>T | p.Leu1569Phe | missense_variant | Exon 33 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.4702C>T | p.Leu1568Phe | missense_variant | Exon 34 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.4216C>T | p.Leu1406Phe | missense_variant | Exon 31 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.3445C>T | p.Leu1149Phe | missense_variant | Exon 27 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.3427C>T | p.Leu1143Phe | missense_variant | Exon 26 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.3289C>T | p.Leu1097Phe | missense_variant | Exon 26 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.3055C>T | p.Leu1019Phe | missense_variant | Exon 24 of 25 | ENSP00000494159.1 | ||||
| SMARCA4 | ENST00000538456.4 | c.859C>T | p.Leu287Phe | missense_variant | Exon 7 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 1631 of the SMARCA4 protein (p.Leu1631Phe). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 408666). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMARCA4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at